Antengene Enters into a Global Clinical Collaboration with MSD to Evaluate ATG-022 (CLDN18.2 ADC) In Combination with KEYTRUDA® (pembrolizumab)

Antengene Enters into a Global Clinical Collaboration with MSD to Evaluate ATG-022 (CLDN18.2 ADC) In Combination with KEYTRUDA® (pembrolizumab)

- ATG-022 is Antengene's CLDN18.2 antibody-drug conjugate; KEYTRUDA® (pembrolizumab) is MSD's anti-PD-1 therapy. SHANGHAI and HONG KONG, May 20, 2025 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative,...

MediThinQ Enters China Through Strategic Partnership with Sinopharm, Making Wearable Surgical Displays a Reality in Operating Theatres

MediThinQ Enters China Through Strategic Partnership with Sinopharm, Making Wearable Surgical Displays a Reality in Operating Theatres

SINGAPORE, May 20, 2025 /PRNewswire/ -- MediThinQ, the South Korean company specialising in wearable extended reality (XR) surgical displays, announced a strategic partnership with Sinopharm, a state-owned Chinese healthcare giant and the largest...

A Game-Changer for QSR: Jollibee Enters Gaming with Octopus&Whale

A Game-Changer for QSR: Jollibee Enters Gaming with Octopus&Whale

MANILLA, Philippines, May 15, 2025 /PRNewswire/ -- Jollibee has just made its boldest move yet — and it all starts with the menu. With the launch of Gamejoy, the beloved fast-food brand steps into the gaming arena with an eat-to-earn campaign that's...

EpicQuest Education Enters into Key Agreement as Catalyst for Recruiting from Africa and the Middle East

EpicQuest Education Enters into Key Agreement as Catalyst for Recruiting from Africa and the Middle East

The New Recruiting Initiative has the Potential to Bring 525 Students from these Regions into Davis University over the Term of the Agreement MIDDLETOWN, Ohio, May 7, 2025 /PRNewswire/ -- EpicQuest Education Group International Limited (NASDAQ:...

Henlius Enters into License Agreement with Sandoz for Proposed Ipilimumab Biosimilar

Henlius Enters into License Agreement with Sandoz for Proposed Ipilimumab Biosimilar

Partnership covers North America, Europe, Japan, and Australia to accelerate global access of HLX13 in immuno-oncology combinations Henlius to receive $31 million upfront, and up to $270 million in milestones SHANGHAI, April 29, 2025 /PRNewswire/ --...

Nanyang Commercial Bank Enters into Strategic Cooperation Agreement with Fosun International

Nanyang Commercial Bank Enters into Strategic Cooperation Agreement with Fosun International

HONG KONG, April 24, 2025 /PRNewswire/ -- On 24 April 2025, Nanyang Commercial Bank ("NCB") and Fosun International Limited ("Fosun International", HKEX stock code: 00656) entered into a strategic cooperation agreement. Sun Jiandong, Executive...

Lidar Industry Enters Mass Adoption Phase, Hesai Remains Leader In Global Market Share

Lidar Industry Enters Mass Adoption Phase, Hesai Remains Leader In Global Market Share

PALO ALTO, Calif., April 11, 2025 /PRNewswire/ -- Hesai Group (Nasdaq: HSAI), the global leader in lidar technology for automotive mobility and robotics application, has been named the top automotive lidar company by market share for the fourth...

Mubadala Energy Enters Major U.S. Upstream Gas and LNG Operation with Kimmeridge

Mubadala Energy Enters Major U.S. Upstream Gas and LNG Operation with Kimmeridge

Equity investment into Kimmeridge's SoTex HoldCo marks Mubadala Energy's U.S. market entry and ambitious expansion strategy Kimmeridge's highly scalable upstream gas and LNG business comprises currently producing upstream gas assets and a pre-FID...

Singaporean lithium-ion battery maker Durapower enters construction machinery sector in partnership with GEBA at Bauma Expo

Singaporean lithium-ion battery maker Durapower enters construction machinery sector in partnership with GEBA at Bauma Expo

The partnership with GEBA marks Durapower's foray into the construction machinery sector Large portfolio of high quality, reliable, and safe battery products and services caters to a wide range of electrification solutions MUNICH and SINGAPORE,...

OSR Holdings, Inc. (NASDAQ: OSRH) Enters Into $80 Million Common Stock Purchase Agreement With White Lion GBM Innovation Fund, With An Eye Towards Leveraging Innovate GBM's Non-Profit Ecosystem to Accelerate Glioblastoma Therapies

OSR Holdings, Inc. (NASDAQ: OSRH) Enters Into $80 Million Common Stock Purchase Agreement With White Lion GBM Innovation Fund, With An Eye Towards Leveraging Innovate GBM's Non-Profit Ecosystem to Accelerate Glioblastoma Therapies

SEOUL, South Korea, April 3, 2025 /PRNewswire/ -- OSR Holdings, Inc. ("OSR") (NASDAQ: OSRH), a global healthcare company focused on advancing innovative therapies, today announced that it has entered into a Common Stock Purchase Agreement with White...

  • 1
  • 2
  • 3
  • menu
    menu